Abstract
INTRODUCTION AND OBJECTIVE:Baseline prostate specific antigen (PSA) is a strong predictor of clinically significant prostate cancer. The combination of baseline PSA with rate of change and current ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
